Skip to content

Organon OGN Intangible assets — net

Intangible assets — net at other companies

Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Biogen logo
BiogenBIIB
AbbVie logo
AbbVieABBV
PBH
Prestige Consumer HealthcarePBH

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's intangible assets — net?
Organon (OGN) reported intangible assets — net of $1.1B in Q1 2026.
How has Organon's intangible assets — net changed year-over-year?
Organon's intangible assets — net decreased by 22.4% year-over-year, from $1.42B to $1.1B.
What is the long-term trend for Organon's intangible assets — net?
Over 5 years (2020 to 2025), Organon's intangible assets — net has grown at a 17.6% compound annual growth rate (CAGR), from $503M to $1.13B.